Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax®) in children
Sarah Ronaldson,1 Matthew Taylor,1 Peter G Bech,2 Ruth Shenton,1 Albrecht Bufe3 1York Health Economics Consortium, York, UK; 2ALK-Abelló A/S, Hørsholm, Denmark; 3Ruhr-Universität Bochum, Bochum, Germany Background: Grass pollen-induced rhinoconjunctivitis is a common...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-04-01
|
| Series: | ClinicoEconomics and Outcomes Research |
| Online Access: | http://www.dovepress.com/economic-evaluation-of-sq-standardized-grass-allergy-immunotherapy-tab-a16384 |